FES antibody

Catalog No. ABIN931483

Product Details anti-FES Antibody

Target: FES (Feline Sarcoma Oncogene (FES))

Reactivity: Human

Host: Mouse

Clonality: Monoclonal

Conjugate: This FES antibody is un-conjugated

Application: Western Blotting (WB), ELISA

Immunogen: FES antibody was raised in Mouse using a purified recombinant fragment of FES expressed in E. coli as the immunogen.

Clone: 5A11G5

Isotype: IgG1

Application Details

Application Notes: ELISA: 1:10,000, WB: 1:500-1:2000
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: Lot specific

Buffer: Supplied as a liquid in ascitic fluid containing 0.03 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handling Advice: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Storage: 4 °C/-20 °C

Storage Comment: Store at 4 °C for short term storage. Store at -20 °C for long term storage.

Target Details for FES

Target: FES (Feline Sarcoma Oncogene (FES))

Alternative Name: FES (FES Products)

Synonyms: FPS antibody, RGD1564385 antibody, AI586313 antibody, BB137047 antibody, c-fes antibody, FES antibody, c-fps antibody, FES proto-oncogene, tyrosine kinase antibody, feline sarcoma oncogene antibody, FES antibody, Fes antibody, fes antibody

Background: FES is the human cellular counterpart of a feline sarcoma retrovirus protein with transforming capabilities. FES has tyrosine-specific protein kinase activity and that activity is required for maintenance of cellular transformation. Its chromosomal location has linked it to a specific translocation event identified in patients with acute promyelocytic leukemia but it is also involved in normal hematopoiesis. Synonyms: Monoclonal FES antibody, Anti-FES antibody, Feline Sarcoma Oncogene antibody, FPS antibody.

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Signaling Events mediated by VEGFR1 and VEGFR2